McKesson Corporation Reports $410.98 Billion Revenue Amid Routine Drug Distribution
1 report, 1 independent
Updated Oct 6
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
McKesson Corporation continued its routine operation of distributing pharmaceuticals to pharmacies across the United States on October 6, 2026. As of October 5, 2026, the company reported collecting $410.98 billion in revenue and maintaining a net margin of 1.12%.
From insidermonkey.com
Why it matters
The company operates by purchasing drugs from manufacturers and delivering them to pharmacies, a model designed to have a thin profit spread. McKesson Corporation reported $6.8 billion in free cash, which is sufficient to cover operating expenses.
From insidermonkey.com
Who's involved
- McKesson CorporationU.S. healthcare supplies distributor
- Brian TylerChief Executive Officer of McKesson Corporation
- Brian S. TylerInsider and CEO of McKesson Corporation
- Boston ScientificReceives healthcare products from McKesson Corporation
Keep exploring
The entities involved
-
McKesson Corporation
U.S. healthcare supplies